Mutations that eliminate DJ-1 expression cause a familial form of Parkinson's disease (PD). In sporadic PD, and many other neurodegenerative diseases, reactive astrocytes over-express DJ-1 whereas neurons maintain its expression at non-disease levels. Since DJ-1 has neuroprotective properties, and since astrocytes are known to support and protect neurons, DJ-1 over-expression in reactive astrocytes may reflect an attempt by these cells to protect themselves and surrounding neurons against disease progression. We used neuronastrocyte contact and non-contact co-cultures to show that DJ-1 knock-down in astrocytes impaired their neuroprotective capacity, relative to wild-type astrocytes, against the neurotoxin rotenone. Conversely, DJ-1 over-expression in astrocytes augmented their neuroprotective capacity. Experiments using astrocyte conditioned media on neuron-only cultures suggested that astrocyte-released, soluble factors were involved in the DJ-1-dependent, astrocyte-mediated neuroprotective mechanism. Our findings support the developing view that astrocytic dysfunction, in addition to neuronal dysfunction, may contribute to the progression of a variety of neurodegenerative disorders.
Introduction
PD and parkinsonism/dementia syndromes are characterized by selective and progressive degeneration of vulnerable neuronal subpopulations within the brainstem, basal ganglia, and cerebral cortex. The development of effective disease-modifying strategies against these disorders will require an improved understanding of the central mechanisms underlying their pathological processes, as well as those through which the brain attempts to protect itself. We propose that the latter process likely involves astrocytes, and that the therapeutic augmentation of mechanisms involved in astrocyte-mediated neuroprotection may represent a novel, and potentially powerful, avenue for the development of new anti-PD/neurodegenerative disease therapies.
Although it is likely that multiple pathological processes contribute simultaneously to PD initiation and progression, oxidative stress is implicated by the abnormal abundance of oxidized proteins, lipids, and nucleic acids in PD brain tissues, and is supported by observations that experimental parkinsonism can be produced in animal models using neurotoxins that induce oxidative stress (Yoritaka et al., 1996; Giasson et al., 2000; Good et al., 1998; Zhang et al., 1999; Castellani et al., 2002; Dexter et al., 1991; Sian et al., 1994; Sherer et al. 2002; Betarbet et al., 2000) . Thus, it is conceivable that PD is caused, at least in part, by chronic, low-level exposure to environmental neurotoxins and that the variability seen in PD susceptibility, presentation, and progression is modulated by complex genetic factors that render individuals either more or less vulnerable to them. In support of this, epidemiological studies have associated high pesticide/herbicide exposure rates with a higher risk of developing PD, and genetic mutations that eliminate the expression of putative neuroprotective proteins (e.g. DJ-1) are known to cause familial PD (Ascherio et al., 2006; Brown et al., 2006; Bonifati et al., 2003; Taira et al., 2004; Zhou and Freed, 2005; Xu et al., 2005) .
Astrocytes, an abundant group of neuron support cells that survive in PD, are known to harbor a powerful neuroprotective arsenal that includes neurotrophic factors and anti-oxidative stress molecules, and astrocyte-derived anti-oxidant molecules can be utilized by surrounding neurons to reduce their own levels of oxidative stress (Damier et al., 1993; Makar et al., 1994; Gegg et al., 2003; Wang and Cynader, 2000; Sagara et al., 1996; Sagara et al., 1993; Dringen et al., 1999) . In sporadic PD brain tissues, reactive astrocytes are robustly immunoreactive for anti-oxidant proteins such as glutathione peroxidase, heme-oxygenase 1, and DJ-1, whereas non-disease astrocytes (and neurons, disease and non-disease) express these proteins at very low levels (Rizzu et al., 2004; Damier et al., 1993; Schipper et al., 1998; Bandopadhyay et al., 2004; Neumann et al., 2004) . Taken together, these observations suggest that astrocytes may attempt to protect themselves and their surrounding neurons against PD progression by over-expressing DJ-1 and other neuroprotective molecules. 
